Device capable of flexibly distributing continuous arterial perfusion medicine dosage
By designing the nested structure of the main catheter and microcatheter, multiple drug injection channels are formed, which solves the problem of inability to flexibly distribute drug dosages in different parts of the liver in the prior art, and achieves the precise treatment of the liver and the effect of reducing normal cell damage. .
Patent Information
- Application Number
- CN202411409111.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-10
- Publication Date
- 2024-11-26
AI Technical Summary
The existing liver chemotherapy drug injection methods cannot flexibly allocate drug doses according to the severity of the disease in different parts of the liver, resulting in insufficient distribution of target tumor drugs or excessive damage to normal hepatocytes, affecting the treatment effect.
A continuous arterial perfusion device including the main catheter and the microcatheter was designed. Multiple injection channels were formed through the nesting combination of the main catheter and the microcatheter, allowing the flexibly allocated drug doses according to the condition needs of different parts and reducing the killing of normal cells. Rate.
Accurate drug distribution to different parts of the liver is achieved, which improves the therapeutic effect and reduces the killing rate of normal cells.
Smart Images

Figure HDA0005077506140000011 
Figure HDA0005077506140000012 
Figure HDA0005077506140000013
Abstract
Description
Technical Field
[0001] The invention relates to the field of medical auxiliary equipment, and in particular to a device capable of flexibly distributing continuous arterial perfusion drug dosages. Background Art
[0002] For patients with liver cancer, whether it is continuous hepatic arterial infusion chemotherapy (HAIC) or transcatheter arterial chemoembolization (TACE) interventional treatment, it is necessary to selectively or super-selectively insert the catheter into the target blood vessel supplying the tumor, and then inject the chemotherapy drugs directly into the target blood vessel in the liver through the catheter at an appropriate speed. The chemotherapy drugs flow into various tissues of the liver through the blood circulation, achieving targeted treatment of the tumor, achieving better treatment effects, and avoiding the side effects of systemic chemotherapy. Since the concentration of chemotherapy drugs injected directly is higher than that of systemic intravenous administration, and local administration is about 200 times greater than the concentration of systemic administration, the damage to normal liver cells is also very large. Since the human liver includes the left and right hemilivers, which can be further divided into five lobes, the volume of the two hemilivers is quite different, and the required amount of drugs is different. At the same time, the degree of canceration of the two hemilivers or five lobes may also be different. For example, the left hemiliver is severely cancerous, and the right hemiliver is slightly cancerous, and the required amount of drugs for the left and right hemilivers will also be different. However, the existing method of injecting drugs into the hepatic aorta first and then allowing the drugs to flow into the various tissue cells of the liver through the blood circulation is obviously unable to inject different doses of chemotherapy drugs according to the treatment needs of different parts of the liver. This can easily lead to insufficient distribution of drugs required by the target tumor, affecting the efficacy, while normal liver cells may be allocated excessive drugs, resulting in a significant increase in the killing rate. Summary of the invention
[0003] In order to solve the above problems, the purpose of the present invention is to provide a dose-distributable arterial continuous perfusion device, which can not only achieve precise attack on tumors in organs, but also flexibly distribute drug doses according to the severity of the disease in different parts of the organs, thereby reducing the killing rate of normal cells.
[0004] To achieve the above object, the present invention adopts the following technical solutions:
[0005] A dose-dispensable arterial continuous perfusion device comprises a main catheter and a microcatheter, wherein a first through hole is axially arranged in the main catheter, a first drug injection port is arranged on the rear end tube wall of the main catheter, a front end head of the main catheter is a first drug outlet, a side opening is arranged on the front end tube wall of the main catheter, the first drug injection port, the first drug outlet and the side opening are all connected with the first through hole; a second through hole is axially arranged in the microcatheter, the microcatheter is penetrated in the first through hole of the main catheter, the front end head of the microcatheter penetrates from the side opening, a first fluid channel is formed between the inner wall of the main catheter and the outer wall of the microcatheter, and the second through hole serves as a second fluid channel.
[0006] More preferably, a plurality of the side openings are provided on the front end tube wall of the main conduit, the side openings are arranged at intervals along the axial direction and a sealing member is provided on each of the side openings.
[0007] More preferably, the sealing member is a film provided with a cross-shaped or Y-shaped slit.
[0008] More preferably, an indicator mark is provided at the side opening.
[0009] The present invention has the following beneficial effects:
[0010] The present invention provides a dose-distributable arterial continuous perfusion device. Through the nesting cooperation of the main catheter and the microcatheter and the ability of the microcatheter to pass through the side opening of the main catheter, a drug injection channel is formed between the inner wall of the main catheter and the outer wall of the microcatheter. The second through hole in the microcatheter serves as an independent drug injection channel, thereby generating two drug injection channels. After calculating the total drug dose, medical personnel can flexibly distribute the drug dose to different parts of the organ according to the severity of the disease in different parts of the organ and other treatment needs, thereby improving the treatment effect and reducing the killing rate of normal cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 It is a structural schematic diagram of the main conduit of the present invention;
[0012] Figure 2 is a schematic structural diagram of the microcatheter of the present invention;
[0013] Figure 3 This is a diagram showing the coordinated use of the main catheter and the microcatheter of the present invention;
[0014] Figure 4 This is a diagram of the use status of the present invention under the guidance of a guide wire.
[0015] Description of reference numerals:
[0016] 10. Main conduit; 11. First through hole; 12. First injection port; 13. Side opening; 14. Sealing member; 15. Indicator mark; 16. First drug outlet; 17. First fluid channel;
[0017] 20. microcatheter; 21. second through hole; 22. second drug injection port; 23. second drug outlet;
[0018] 30. Guide wire; 40. Left hepatic artery; 50. Common hepatic artery; 60. Proper hepatic artery; 70. Right hepatic artery. DETAILED DESCRIPTION
[0019] The present invention is further described in detail below with reference to the accompanying drawings and specific embodiments:
[0020] See also Figures 1 to 3, a dose-dispensable arterial continuous perfusion device, comprising a main catheter 10 and a microcatheter 20. A first through hole 11 is axially provided in the main catheter 10, a first drug injection port 12 is provided on the rear end wall of the main catheter 10, a front end head of the main catheter 10 is a first drug outlet 16, and the rear end opening of the main catheter 10 can be used to insert a guide wire 30 and to insert the microcatheter 20 after the guide wire 30 is pulled out. A side opening 13 is provided on the front end wall of the main catheter 10, and the first drug injection port 12, the side opening 13 and the first drug outlet 16 are all connected to the first through hole 11. A second through hole 21 is axially provided in the microcatheter 20, the microcatheter 20 is inserted in the first through hole 11 of the main catheter 10 and the front end head of the microcatheter 20 is inserted from the side opening 13. A first fluid channel 17 is formed between the inner wall of the main catheter 10 and the outer wall of the microcatheter 20. For example, the inner diameter of the main catheter 10 is in the range of 1.32-1.99 mm, i.e. 4.0-6.0 Fr., and the outer diameter of the microcatheter 20 is in the range of 0.74-0.9 mm, i.e. 2.2-2.7 Fr. After the microcatheter 20 is inserted into the main catheter 10, a gap formed by the difference between the inner and outer diameters between the two is used as the first fluid channel 17. The second through hole 21 is used as the second fluid channel, and the rear end opening of the second through hole 21 is the second drug injection port 22, and the front end opening is the second drug outlet 23. Since the main catheter 10 first enters the first artery that needs to be injected with drugs, and the microcatheter 20 enters the second artery that needs to be injected with drugs, and the relative position between the second artery and the first artery is determined according to the actual treatment needs, in order to improve the adaptability of the microcatheter 20 to the position of the second artery, a plurality of side openings 13 are provided on the front end tube wall of the main catheter 10, and each of the side openings 13 is arranged at intervals along the axial direction. For example, the frontmost side opening 13 is 3 to 5 cm away from the front end of the main catheter 10, and then a side opening 13 is opened every 1 cm, and 5 side openings 13 are distributed at equal intervals. The microcatheter 20 can select one of the side openings 13 to pass through according to the location of the second artery. Preferably, in order to accurately control the injection dose and prevent the drug that needs to be injected into the first artery from leaking from the remaining side openings 13, each of the side openings 13 is provided with a sealing member 14, and the sealing member 14 is a film or sheet with a cross-shaped or Y-shaped slit, such as a thin silicone film or a thin silicone sheet.
[0021] Preferably, in order to make it easier for the operator to locate the side opening 13 under fluoroscopy or X-ray, an indicator mark 15 is provided at the side opening 13. The indicator mark 15 can be "T"-shaped, and can be an indicator ring arranged along the edge of the side opening 13.
[0022] When the main catheter 10 needs to turn a certain angle to enter the first artery, or when the microcatheter 20 needs to turn a certain angle to pass through the side opening 13, the head section of the guide wire 30 can be shaped and slightly bent at a certain angle before entering. Exemplarily, the range of the angle α at the bend of the guide wire 30 is: 90°≤α≤170°.
[0023] Since the guide wire 30 is a commonly used auxiliary accessory during arterial catheterization and is a well-known technology in the artery, the present device also needs the guide wire 30 to cooperate with the guide wire during actual use. Now, taking the main catheter 10 entering the right hepatic artery 70 and the microcatheter 20 entering the left hepatic artery 40 as an example, the use process of the present device is as follows: Figure 4 First, the guide wire 30 is used to cooperate with the main catheter 10 to enter the femoral artery, pass through the hepatic aorta 50 and the proper hepatic artery 60, and enter the right hepatic artery 70. Since there is a certain angle between the position of the right hepatic artery 70 and the proper hepatic artery 60, before entering the route, the head of the guide wire 30 is slightly bent, and then inserted into the main catheter 10, so that the guide wire 30 can guide the main catheter 10 to enter the right hepatic artery 70 smoothly. The main catheter 10 is rotated to ensure that the side opening 13 on the main catheter 10 faces the left hepatic artery 40, and then the guide wire 30 is withdrawn. The guide wire 30 is inserted into the microcatheter 20, and then the microcatheter 20 is inserted into the first through hole 11 of the main catheter 10. When the microcatheter 20 reaches the vicinity of the side opening 13, the thin film on the side opening 13 is pushed open by the guide wire 30 or the microcatheter 20, and the guide wire 30 passes through the side opening 13, and then the microcatheter 20 passes through the side opening 13 along the guide wire 30, enters the left hepatic artery 40, and the guide wire 30 is withdrawn. Next, contrast agent is injected through the first injection port 12 and the second injection port 22 respectively to confirm whether the main catheter 10 and the microcatheter 20 have reached the required position. After confirmation, the main catheter 10 and the microcatheter 20 are fixed. Finally, the total dose of the drug is calculated, and the dose of the drug injected from the main catheter 10 and the dose of the drug injected from the microcatheter 20 are flexibly allocated according to the treatment needs. The drugs are injected separately. The drug injected from the first injection port 22 flows out from the first drug outlet 16 after passing through the first fluid channel 17 and enters the right hepatic artery. The drug injected from the second injection port 22 flows out from the second drug outlet 23 after passing through the second through hole 21 and enters the left hepatic artery 40. It should be noted that the flow path of the contrast agent is the same as the flow path of the drug.
[0024] The device is not limited to the femoral artery approach, but can also be used for the radial artery approach. At the same time, the device is not limited to the liver injection, but can also be used for other organs injection.
[0025] The above description is only a specific implementation mode of the present invention, and does not limit the patent scope of the present invention. Any equivalent structural transformation made by using the contents of the present invention description and drawings, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.
Claims
1. A dose-dispensable continuous arterial infusion device, Features: It comprises a main catheter and a microcatheter, wherein a first through hole is axially arranged in the main catheter, a first drug injection port is arranged on the rear end tube wall of the main catheter, a front end head of the main catheter is a first drug outlet, a side opening is arranged on the front end tube wall of the main catheter, the first drug injection port, the first drug outlet and the side opening are all connected with the first through hole; a second through hole is axially arranged in the microcatheter, the microcatheter is penetrated in the first through hole of the main catheter, the front end head of the microcatheter passes out from the side opening, a first fluid channel is formed between the inner wall of the main catheter and the outer wall of the microcatheter, and the second through hole serves as a second fluid channel.
2. A dose-dispensable continuous arterial infusion device according to claim 1, Features: A plurality of side openings are arranged on the front end tube wall of the main conduit, each of the side openings is arranged at intervals along the axial direction and each of the side openings is provided with a sealing member.
3. A dose-dispensable arterial continuous infusion device according to claim 1, Features: The sealing member is a film with a cross-shaped or Y-shaped slit.
4. A dose-dispensable arterial continuous infusion device according to claim 1, Features: An indication mark is arranged at the side opening.
Citation Information
Cited By
Specialized microcatheter for haic with spoiler
CN123024250A
